Cargando…

Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry

Accurately identifying time-varying differences in the hazard of all-cause mortality after liver transplantation (LT) between recipients with and without hepatocellular carcinoma (HCC) may inform patient selection and organ allocation policies as well as post-LT surveillance protocols. METHODS. A UK...

Descripción completa

Detalles Bibliográficos
Autores principales: Sehjal, Jyoti, Sharples, Linda D., Keogh, Ruth H., Walker, Kate, Prachalias, Andreas, Heaton, Nigel, Ivanics, Tommy, van der Meulen, Jan, Wallace, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592162/
https://www.ncbi.nlm.nih.gov/pubmed/36017919
http://dx.doi.org/10.1097/TP.0000000000004282
_version_ 1784814861175226368
author Sehjal, Jyoti
Sharples, Linda D.
Keogh, Ruth H.
Walker, Kate
Prachalias, Andreas
Heaton, Nigel
Ivanics, Tommy
van der Meulen, Jan
Wallace, David
author_facet Sehjal, Jyoti
Sharples, Linda D.
Keogh, Ruth H.
Walker, Kate
Prachalias, Andreas
Heaton, Nigel
Ivanics, Tommy
van der Meulen, Jan
Wallace, David
author_sort Sehjal, Jyoti
collection PubMed
description Accurately identifying time-varying differences in the hazard of all-cause mortality after liver transplantation (LT) between recipients with and without hepatocellular carcinoma (HCC) may inform patient selection and organ allocation policies as well as post-LT surveillance protocols. METHODS. A UK population-based study was carried out using 9586 LT recipients. The time-varying association between HCC and post-LT all-cause mortality was estimated using an adjusted flexible parametric model (FPM) and expressed as hazard ratios (HRs). Differences in this association by transplant year were then investigated. Non–cancer-specific mortality was compared between HCC and non-HCC recipients using an adjusted subdistribution hazard model. RESULTS. The HR comparing HCC recipients with non-HCC recipients was below one immediately after LT (1-mo HR = 0.76; 95% confidence interval [CI], 0.59-0.99; P = 0.044). The HR then increased sharply to a maximum at 1.3 y (HR = 2.07; 95% CI, 1.70-2.52; P < 0.001) before decreasing. The hazard of death was significantly higher in HCC recipients than in non-HCC recipients between 4 mo and 7.4 y post-LT. There were no notable differences in the association between HCC and the post-LT hazard of death by transplant year. The estimated non–cancer-specific subdistribution HR for HCC was 0.93 (95% CI, 0.80-1.09; P = 0.390) and not found to vary over time. CONCLUSIONS. FPMs can provide a more precise comparison of post-LT hazards of mortality between HCC and non-HCC patients. The results provide further evidence that some HCC patients have extra-hepatic spread at the time of LT, which has implications for optimal post-LT surveillance protocols.
format Online
Article
Text
id pubmed-9592162
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-95921622022-10-27 Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry Sehjal, Jyoti Sharples, Linda D. Keogh, Ruth H. Walker, Kate Prachalias, Andreas Heaton, Nigel Ivanics, Tommy van der Meulen, Jan Wallace, David Transplantation Original Clinical Science—Liver Accurately identifying time-varying differences in the hazard of all-cause mortality after liver transplantation (LT) between recipients with and without hepatocellular carcinoma (HCC) may inform patient selection and organ allocation policies as well as post-LT surveillance protocols. METHODS. A UK population-based study was carried out using 9586 LT recipients. The time-varying association between HCC and post-LT all-cause mortality was estimated using an adjusted flexible parametric model (FPM) and expressed as hazard ratios (HRs). Differences in this association by transplant year were then investigated. Non–cancer-specific mortality was compared between HCC and non-HCC recipients using an adjusted subdistribution hazard model. RESULTS. The HR comparing HCC recipients with non-HCC recipients was below one immediately after LT (1-mo HR = 0.76; 95% confidence interval [CI], 0.59-0.99; P = 0.044). The HR then increased sharply to a maximum at 1.3 y (HR = 2.07; 95% CI, 1.70-2.52; P < 0.001) before decreasing. The hazard of death was significantly higher in HCC recipients than in non-HCC recipients between 4 mo and 7.4 y post-LT. There were no notable differences in the association between HCC and the post-LT hazard of death by transplant year. The estimated non–cancer-specific subdistribution HR for HCC was 0.93 (95% CI, 0.80-1.09; P = 0.390) and not found to vary over time. CONCLUSIONS. FPMs can provide a more precise comparison of post-LT hazards of mortality between HCC and non-HCC patients. The results provide further evidence that some HCC patients have extra-hepatic spread at the time of LT, which has implications for optimal post-LT surveillance protocols. Lippincott Williams & Wilkins 2022-08-26 2022-11 /pmc/articles/PMC9592162/ /pubmed/36017919 http://dx.doi.org/10.1097/TP.0000000000004282 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Clinical Science—Liver
Sehjal, Jyoti
Sharples, Linda D.
Keogh, Ruth H.
Walker, Kate
Prachalias, Andreas
Heaton, Nigel
Ivanics, Tommy
van der Meulen, Jan
Wallace, David
Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry
title Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry
title_full Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry
title_fullStr Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry
title_full_unstemmed Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry
title_short Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry
title_sort time-varying comparison of all-cause mortality after liver transplantation between recipients with and without hepatocellular carcinoma: a population-based cohort study using the united kingdom liver transplant registry
topic Original Clinical Science—Liver
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592162/
https://www.ncbi.nlm.nih.gov/pubmed/36017919
http://dx.doi.org/10.1097/TP.0000000000004282
work_keys_str_mv AT sehjaljyoti timevaryingcomparisonofallcausemortalityafterlivertransplantationbetweenrecipientswithandwithouthepatocellularcarcinomaapopulationbasedcohortstudyusingtheunitedkingdomlivertransplantregistry
AT sharpleslindad timevaryingcomparisonofallcausemortalityafterlivertransplantationbetweenrecipientswithandwithouthepatocellularcarcinomaapopulationbasedcohortstudyusingtheunitedkingdomlivertransplantregistry
AT keoghruthh timevaryingcomparisonofallcausemortalityafterlivertransplantationbetweenrecipientswithandwithouthepatocellularcarcinomaapopulationbasedcohortstudyusingtheunitedkingdomlivertransplantregistry
AT walkerkate timevaryingcomparisonofallcausemortalityafterlivertransplantationbetweenrecipientswithandwithouthepatocellularcarcinomaapopulationbasedcohortstudyusingtheunitedkingdomlivertransplantregistry
AT prachaliasandreas timevaryingcomparisonofallcausemortalityafterlivertransplantationbetweenrecipientswithandwithouthepatocellularcarcinomaapopulationbasedcohortstudyusingtheunitedkingdomlivertransplantregistry
AT heatonnigel timevaryingcomparisonofallcausemortalityafterlivertransplantationbetweenrecipientswithandwithouthepatocellularcarcinomaapopulationbasedcohortstudyusingtheunitedkingdomlivertransplantregistry
AT ivanicstommy timevaryingcomparisonofallcausemortalityafterlivertransplantationbetweenrecipientswithandwithouthepatocellularcarcinomaapopulationbasedcohortstudyusingtheunitedkingdomlivertransplantregistry
AT vandermeulenjan timevaryingcomparisonofallcausemortalityafterlivertransplantationbetweenrecipientswithandwithouthepatocellularcarcinomaapopulationbasedcohortstudyusingtheunitedkingdomlivertransplantregistry
AT wallacedavid timevaryingcomparisonofallcausemortalityafterlivertransplantationbetweenrecipientswithandwithouthepatocellularcarcinomaapopulationbasedcohortstudyusingtheunitedkingdomlivertransplantregistry